Biography

Dr Cheng-Hon Yap is a Cardiothoracic Surgeon located at the Geelong Hospital and St John of God Geelong Hospital, where he is also the Clinical Lead of Cardiac Services. He also holds teaching positions as a Clinical Senior Lecturer in the School of Medicine, Faculty of Health at the Deakin University and is an Adjunct Senior Research Fellow in the Department of Epidemiology and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences at the Monash University.

Dr Yap completed his Bachelor of Medicine, Bachelor of Surgery at the University of Melbourne, and later obtained his Master of Surgery by thesis, from his research on “Factors influencing cryopreserved allograft heart valve degeneration.” He completed training at The Royal Melbourne Hospital, St Vincent’s Hospital Melbourne and the Austin Hospital, completing his fellowship of the Royal Australasian College of Surgeons in 2011. Following this, Cheng also completed Cardiac Surgery Clinical post-fellowship training at the Bristol Heart Institute, Bristol, Avon, UK.

Dr Yap performs a wide range of cardio-thoracic procedures including VATS lung resections, aortic surgery, minimally invasive aortic valve and coronary revascularisation procedures.

Dr Yap has contributed his knowledge and experience to many publications and presentations. He is currently a Chief Investigator of two research projects including the Victorian Lung Cancer Registry at St John of God Geelong Hospital and Stable-Mates Trial at the University Hospital Geelong.

Cheng has continued to further his skills attending a number of scientific meetings, courses and workshops. He has been an invited reviewer of the Heart, Lung Circulation (2011-2016), Circulation (2011), Heart (2011), International Journal of Medical Sciences (2007), and European Journal of Clinical Investigation (2006).  Along with numerous leadership and advisory roles mentioned below, Dr Yap was also an NHMRC Project Grant External Assessor and the Chair of the Lung Cancer Working Group, Barwon Health Cancer Programme.

Procedures & Conditions

Procedures Performed
  • VATS Lung Resection
  • Aortic Surgery
  • Minimally Invasive Aortic Valve
  • Coronary Revascularisation Procedures
Conditions Treated
  • Aortic Stenosis
  • Aortic Valve Disease
  • Coronary Artery Disease
  • Lung Cancer

Experience

  • Consultant Cardiothoracic Surgeon
    The Geelong Hospital
  • Visiting Cardiothoracic Surgeon and Clinical Lead (Cardiac Services)
    St John of God Geelong Hospital
  • Clinical Senior Lecturer
    School of Medicine, Faculty of Health, Deakin University
  • Adjunct Senior Research Fellow
    Department of Epidemiology and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University
  • Cardiac Surgery Clinical Fellow
    Bristol Heart Institute, Bristol, Avon, UK 2010 - 2011

Memberships

Professional Memberships and Affiliations
  • International Association for the study of Lung Cancer

  • Australian and New Zealand Society of Cardiac and Thoracic Surgeons

  • Royal Australasian College of Surgeons

  • Australian Medical Association

  • 2018 - Present

    Barwon South West Regional Integrated Cancer Service Clinical Advisory Group

  • 2015 - Present

    Evaluation of Cancer Outcomes Barwon South West Steering Committee

  • 2016 - Present

    Editorial Board Member, Journal of Thoracic Disease

  • 2013 - Present

    Supervisor of Training, Cardiothoracic Surgery, Geelong Hospital

  • 2011 - Present

    Australasian Society of Cardiac and Thoracic Surgeons Database Research Committee Member

Awards
  • 2009

    Edwards Lifesciences Travelling Fellowship, Australasian Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting

  • 2009

    St Jude Medical Travel Grant, Society of Cardiothoracic Surgery in Great Britain and Ireland Annual Meeting

  • 2008

    Bayer Young Surgeon Travel Fellowship, Society of Thoracic Surgeons Meeting

  • 2006

    Senior Medical Association Prize for Best Clinical / Allied Health Junior Investigator Presentation on the Day & Prize for Junior Investigator Presentation

  • 2005

    Barwon Health Registrar Teaching Prize

  • 2004

    St Vincent's Hospital Melbourne grant-in-aid for research project

  • 2004

    Barwon Health HMO Prize

Research & Publications

Publications

1. Ye S, Cowled J, Yap CH, STambas J. Deep sequencing of primary human lung epithelial cells challenged with H5N1 influenza virus reveals a proviral role for CEACAM1. Sci Rep. 2018 Oct 19;8(1):15468. doi: 10.1038/s41598-018-33605-6.

2. Ariyaratne TV, Ademi Z, Huq M, Rosenfeldt F, Duffy SJ, Parkinson B, Yap CH, Smith J, Billah B, Yan BP, Brennan AL, Tran L, Reid CM. The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score Matched Analysis of a Single Centre Experience. Appl Health Econ Health Policy. 2018 Oct;16(5):661-674. doi:10.1007/s40258-018-0407-5.

3. Seitz M, Goldblatt J, Paul E, Marcus T, Larobina M, Yap CH. Minimally Invasive Aortic Valve Replacement Via Right Anterior Mini-Thoracotomy: Propensity Matched Initial Experience. Heart Lung Circ. 2017 Dec 7. pii: S1443-9506(17)31506-8. doi: 10.1016/j.hlc.2017.11.012

4. Power P, Bone A, Simpson N, Yap CH, Gower S, Bailey M. Comparison of pulmonary artery catheter, echocardiography, and arterial waveform analysis monitoring in predicting the hemodynamic state during and after cardiac surgery. Int J Crit Illn Inj Sci. 2017 Jul-Sep;7(3):156-162. doi: 10.4103/2229-5151.214411.

5. Kohli N, Mitreski G, Yap CH, Leong M. Massive Symptomatic Right Sided Bochdalek Hernia in an Adult Male. BMJ Case Rep. 2016 Nov 15;2016. pii: bcr2016217432. doi: 10.1136/bcr-2016-217432.

6. Ariyaratne TV, Yap CH, Ademi Z, Rosenfeldt F, Duffy SJ, Billah B, Reid CM. A systematic review of cost-effectiveness of percutaneous coronary intervention versus surgery for the treatment of multi-vessel coronary artery disease in the drug-eluting stent era. European Heart Journal – Quality of Care and Clinical Outcomes 2016; 2(4): 261-270. doi:http://dx.doi.org/10.1093/ehjqcco/qcw007.

7. Dixon B, Smith R, Santamaria JD, Orford NR, Wakefield BJ, Ives K, McKenzie R, Zhang B, Yap CH. A trial of nebulised heparin to limit lung injury following cardiac surgery. Anaesth Intensive Care. 2016; 44(1):28-33.

8. Srivastava V, Yap CH, Burdett C, Smailes T, Kendall S, Akowuah E. Thermoreactive clips do not reduce sternal infection rates: a propensity-matched comparison with sternal wires. Interact Cardiovasc Thorac Surg. 2015; 21(6):699-704. doi: 10.1093/icvts/ivv238.

9. Robertson L, Holdaway D, Yap CH. Retrograde Type A Aortic Dissection Treated with Continuous Perfusion “Branch-First” Aortic Arch Replacement Technique. Heart Lung Circ. 2015; 24(12):e206-9. doi: 10.1016/j.hlc.2015.07.004.

10. Ariyaratne TV, Ademi Z, Yap CH, Billah B, Rosenfeldt F, Yan BP, Reid CM. Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: An updated systematic review and meta-analysis. Int J Cardiol 2014.20;176(2):346-53. doi: 10.1016/j.ijcard.2014.06.072

11. Shi WY, Yap CH, Newcomb AE, Tran L, Reid CM, Shardey GC, Smith JA. Impact of socioeconomic status and rurality on early outcome and mid-term survival after CABG: Insights from a multicentre registry. Heart Lung Circ. 2014; 23(8):726-36. doi: 10.1016/j.hlc.2014.02.008

12. Dixon B, Reid D, Collins M, Newcomb AE, Rosalion A, Yap CH, Santamaria JD, Campbell D. The operating surgeon is an independent predictor of chest tube drainage following cardiac surgery. J Cardiothorac Vasc Anesth. 2014; 28(2):242-6. doi: 10.1053/j.jvca.2013.09.010.

13. Ariyaratne TV, Ademi Z, Duffy SJ, Andrianopoulos N, Billah B, Brennan AL, New G, Black A, Ajani AE, Clark DJ, Yan BP, Yap CH, Reid CM. Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: Data from a large multi-centre Australian registry. Int J Cardiol. 2013;168:2783-90. doi: 10.1016/j.ijcard.2013.03.128.

14. Bagherirad MA, Entesari-Tatafi D, Mirzaee S, Appelbe A, Yap C, Athan E. A case of Kingella kingae endocarditis complicated by native mitral valve rupture. Australas Med J 2013, 6 (4): 172-174. http//dx.doi.org/10.4066/AMJ.2013.1577

15. Hayward PAR, Yap CH, Shi WY, Buxton B, Dinh DT, Reid C, Shardey GC, Smith JA. Does the addition of a radial artery graft improve survival after higher risk coronary artery bypass grafting? A propensity-score analysis of a multicentre database. Euro J Cardiothorac Surg 2013; 44(3):497-505. doi: 10.1093/ejcts/ezt116.

16. Goh SS, Yap CH. Massive saddle pulmonary embolus. J Card Surg. 2012 Nov;27(6):720. Chan J, Kumar J, Cheng A, Yap CH, Zhang XB. Right Atrial Mass Associated with a Dialysis Catheter. J Card Surg. 2012;27(3):362.

17. Saxena A, Dinh D, Yap CH, Reid CM, Billah B, Smith JA, Shardey GC, Newcomb AE. Critical analysis of early and late outcomes after isolated coronary artery bypass surgery in elderly patients. Ann Thorac Surg 2011; 92:1703-11.

18. Shi WY, Hayward PAR, Yap CH, Dinh DT, Smith JA. Training in mitral valve surgery need not affect early outcomes and mid-term survival: a multicentre analysis. Eur J Cardiothorac Surg 2011; 40:826-33.

19. Shi WY, Yap CH, Hayward PA, Dinh DT, Reid CM, Shardey GC, Smith JA. Impact of prosthesis-patient mismatch after mitral valve replacement: a multicentre analysis of early outcomes and mid-term survival. Heart 2011; 97:1074-1081.

20. Ariyaratne TV, Billah B, Yap CH, Dinh D, Smith JA, Shardey GC, Reid CM. An Australian risk prediction model for determining early mortality following aortic valve replacement. Euro Eur J Cardiothorac Surg 2011; 39:815-21.

21. Andrianopoulos N, Dinh D, Duffy SJ, Clark DJ, Brennan AL, Chan W, Shardey GC, Smith JA, Yap CH, Buxton BF, Ajani AE, Reid CM. Quality Control Activities Associated with Registries in Interventional Cardiology and Surgery. Heart Lung Circ. 2011; 20:180-6.

22. Chan W, Clark DJ, Ajani AE, Yap CH, Andrianopoulos N, Brennan AL, Dinh D, Shardey GC, Smith JA, Reid CM, Duffy SJ. Progress Towards a National Cardiac Procedure Database – Development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) Registries. Heart Lung Circ 2011; 20:10-8.

23. Yap CH, Yan BP, Akowuah E, Dinh DT, Smith JA, Shardey GC, Tatoulis J, Skillington PD, Newcomb A, Mohajeri M, Pick A, Seevanayagam S, Reid CM. Does prior percutaneous coronary intervention adversely affect early and long-term survival after coronary artery surgery? JACC Cardiovasc Interv 2009; 2:758-64.

24. Yap CH, Andrianopoulos N, Dinh DT, Billah B, Rosalion A, Smith JA, Shardey GC, Skillington PD, Tatoulis J, Mohajeri M, Yii M, Reid CM. Short and mid-term outcomes of coronary artery bypass surgery performed by surgeons in training. J Thorac Cardiovasc Surg 2009; 137:1088-92.

25. Yap CH, Sposato L, Akowuah E, Theodore S, Dinh DT, Shardey GC, Skillington PD, Tatoulis J, Yii M, Smith JA, Mohajeri M, Pick A, Seevanayagam S, Reid CM. Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann Thorac Surg 2009; 87:1386–91.

26. Tatoulis J, Theodore S, Meswani M, Wynne R, Yap CH, Powar N. Safe use of recombinant activated factor VIIA for recalcitrant postoperative haemorrhage in cardiac surgery. Interact Cardiovasc Thorac Surg 2009; 9:459-462.

27. Sposato LA, Yap CH, Powar N, Alizzi AM, Tatoulis J, Newcomb AE. Acute mediastinitis secondary to venous perforation by a peripherally inserted central venous catheter. J Cardiothorac Vasc Anesth 2009; 23:672-4.

28. Yan BP, Clark DJ, Buxton B, Ajani AE, Smith JA, Duffy, Shardy G, Farouque O, Yii M, Yap CH, Adrianopoulos N, Brennan A, Reid CM. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Heart Lung Circ 2009; 18:184-90.

29. Daniels M, Yap CH, Nandurkar H, MacIsaac A and Yii M. Inflammatory Myocardial Injury: The Role of Lymphocytes in Atherosclerosis and Other Heart Disease. J Organ Dysfunction 2009; 5:224-232.

30. Yap CH, Lau L, Krishnaswamy M, Gaskell M and Yii M. Age of transfused red cells and early outcomes following cardiac surgery. Ann Thorac Surg 2008; 86:554-9.

More research publications available upon request.

View More

Presentations

Presenting Author

  • Yap CH, Seitz M, Zhang B. Sutureless aortic valve replacement: an alternative to TAVI? (Invited). International Congress of Cardiology, Chinese University of Hong Kong -Mayo Clinic-Asia Cardiovascular Summit & 2nd Antithrombotic Pharmaceutical Symposium, 13-14 April 2013. Lee Shau Kee Building, Central Campus, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong.
  • Yap CH. Toward eliminating deep sternal wound infection in cardiac surgery (Invited). Australasian Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting, Noosa Heads, Queensland Australia. 5-8 Nov 2009.
  • Yap CH. Australasian Society of Cardiac and Thoracic Surgeons Database Research Report (Invited). Festschrift for Brian Buxton. Langham Hotel, Melbourne. 13th June 2009.
  • Yap CH, Akowuah E, Yan BP, Dinh D, Reid CM, Skillington P, Tatoulis J. Does Prior Percutaneous Intervention Influence Mortality After Coronary Artery Bypass Graft Surgery? Society For Cardiothoracic Surgery In Great Britain and Ireland Annual Meeting. Bournemouth, United Kingdom. 22-24 March 2009.
  • Yap CH, Mohajeri M, Yii M. Obesity and early complications following cardiac surgery. 56th European Society for Cardiovascular Surgery International Congress, Venice, Italy 19th May 2007. Interactive Cardiovasc Thorac Surg 2007; 6 (Suppl 1): S32.
  • Yap CH, Kenny JF, Zimmet A, Mohajeri M, Yii M. Effect of obesity on early morbidity and mortality following cardiac surgery. 59th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery, Tokyo, Japan. 3rd Oct 2006.
  • Yap CH, Mohajeri M, Yii M. Prosthesis-patient mismatch is associated with higher operative mortality following aortic valve replacement. 59th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery, Tokyo, Japan. 3rd Oct 2006.
  • Yap CH. Nixon I, Skillington PD, Matalanis G, Davis B, Tait BD, Hudson F, Ireland L, Yii M. Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at 3-year follow-up. Australasian Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting, Noosa Heads, Queensland, Australia. 29th October 2005. Heart, Lung and Circulation 2006; 15:80.
  • Yap C-H, Hawkins JH, Natarajan D, Ihle BU, Wilson AC, Yii M. Validation of EuroSCORE model in an Australian population. Royal Australasian College of Surgeons Annual Scientific Congress, Melbourne, Australia, 3rd May 2004. ANZ J Surg 2004; 74(Suppl):A26.
  • Yap C-H, Prior D, Kalman J, Wilson AC, Mooney D, Yii M. Cox-Maze III mid-term results. Royal Australasian College of Surgeons Annual Scientific Congress, Melbourne, Australia. 4th May 2004. ANZ J Surg 2004; 74(Suppl):A27.

Electronic Poster Presentation

  • Yap CH, Skillington PD, Matalanis G, Davis BB, Tait BD, Hudson F, Ireland L, Yii M. HLA-mismatch and other factors affecting cryopreserved allograft valve degeneration. European Association for Cardiothoracic Surgery and the European Society of Thoracic Surgeons 5th Joint Meeting, Stockholm, Sweden Sept 13 2006. Interactive Cardiovasc Thorac Surg 2006; 5(Suppl 2):S245.

Poster Presentations

  • Kim M, Thapa B, Yap CH. Outcomes of VATS lung resections in a regional service. Australia and New Zealand Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting. Noosa, QLD. 8-10 Nov 2018.
  • Thakur S, Kim M, Holdaway D, Yap CH. Dysphagia Lusoria. Tongariro Cardiac Surgery Meeting, Rotorua, New Zealand. 16-18 Mar 2018.
  • Ariyaratne T, Ademi Z, Huq M, Duffy S, Billah B, Rosenfeldt F, Parkinson B, Yap C, Yan B, Smith J, Brennan A, Tran L, Reid C. The real-world cost-effectiveness of coronary artery bypass grafting versu stenting in high-risk patients: propensity score analysis of a single centre experience. International Society for Pharmacoeconomics and Outcomes Research 21st Annual International Meeting. Washington DC, USA. 21-25 May 2016.
  • Lay J, Cheng A, Yap CH, Zhang B. Sutureless Aortic Valve Replacement: Early Experiences from Barwon Health. Australia and New Zealand Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting. Gold Coast, Queensland, Australia. 9th – 12th November 2014.
  • Aryiyaratne TV, Ademi Z, Yap CH, Billah B, Rosenfeldt F, Yan BP, Reid CM. Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease. International Society for Pharmacoeconomics and Outcomes Research 15th Annual European Congress. 3-7 November 2012. Berlin, Germany. Value In Health 2012; 15:A402.
  • Chan J, Naidu P, Cheng A, Kumar J, Appelbe A, Hiew C, Black A, Yap C, Zhang X. Accuracy of Industry Generated Effective Orifice Area Calculators for Aortic Valve Replacement. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting, 16-19 August 2012, Brisbane. Heart, Lung and Circulation 2012; 21(S1): S274.
  • Naidu P, Chan J, Yap C, Hiew C. Long-Term Clinical Outcomes after Coronary Artery Bypass Surgery in Patients With Ischaemic Cardiomyopathy With or Without Preoperative Myocardial Viability Study. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting, 16-19 August 2012, Brisbane Heart, Lung and Circulation 2012; 21(S1): S280.
  • C H Yap, P A Hayward, W Y Shi, D T Dinh, C M Reid, G C Shardey, J A Smith. Does the addition of a radial artery graft improve survival after higher risk coronary surgery? A Propensity-Score analysis. British Cardiovascular Society Annual Conference 13–15 June 2011 Manchester Central. Heart 2011;97:A9 doi:10.1136/heartjnl-2011-300198.8
  • Shi WY, Yap CH, Hayward PA, Dinh DT, Reid CM, Shardey GC, Smith JA. Impact of patient-prosthesis mismatch after mitral valve replacement: an Australian multicentre analysis of early outcomes and mid-term survival. Australasian Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting, Hamilton Island, Queensland, Australia. 4-7 November 2010. Heart, Lung and Circulation 2011; 20:282.
  • Nandapurkar M, Yap CH, Kenny J, Zhang B, Athan E, Mohajeri M. A Regional Cardiothoracic unit experience with Infective Endocarditis. Australasian Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting, Hamilton Island, Queensland , Australia. 4-7 November 2010. Heart, Lung and Circulation 2011; 20:279.
  • Yan BP, Yap CH, Andrianopoulos N, Kiernan TJ, Ajani AE, Smith JA, Clark DJ, Duffy SJ, Shardey GC, Brennan AL, Dinh DT, Reid CM, Gersh BJ. Prognostic value of the Mayo Clinic Risk Score for coronary artery revascularisation using the Australasian Society of Cardiac and Thoracic Surgeons and Melbourne Interventional Group registries. American College of Cardiology’s 59th Annual Scientific Session and i2 Summit, Atlanta, USA, Mar 14-16 2010. J. Am. Coll. Cardiol. 2010;55;A134.E1257.
  • Ariyaratne T, Yap CH, Billah B, Brasacchio D, Dinh D, Smith JA. Validation of current valve-specific risk models in the Australian population. Australasian Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting, Noosa Heads, Queensland Australia. 5-8 Nov 2009. Heart, Lung and Circulation 2010; 20:55.
  • Cheng A, Wainer Z, Eapen R, Alam N, Yap CH, Wright GM. The proposed IASLC seventh revision for non-small cell lung cancer staging: prognostic validation using a surgical series. 13th World Conference on Lung Cancer. San Francisco, CA July 31-August 4, 2009. Journal of Thoracic Oncology 2009; 4(Supplement 1), S561.
  • Cheng A, Lim WH, Wainer Z, Eapen R, Alam N, Russell P, Opeskin K, Yap CH, Wright GM. Comparing VATS and open mediastinal lymph node dissection according to the proposed nodal zones of the IASLC staging committee. Royal Australasian College of Surgeons Annual Scientific Congress. Brisbane, Australia. 6-9th May 2009. ANZ J Surg 2009; 79 (Suppl 1): A80.
  • Dinh DT, Billah B, Yap CH, Shardey GC, Reid C. Blood Product Utilisation in Cardiac Surgery Findings from the ASCTS Database Project. Australasian Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting and Heart Failure Symposium, Noosa Heads, Queensland, Australia. 17-21th October 2007. Heart, Lung and Circulation 2009; 18:85-86.
  • Alam N, Cheng A, Yap CH, Russell P, Opeskin K, Wright GM. Comparison of Mediastinal Lymph Node Dissection by VATS and Thoracotomy. 12th World Conference on Lung Cancer, Seoul, Korea. 2-6 Sept 2007. Journal of Thoracic Oncology 2007; 2(8): S769.
  • Cheng A, Yap CH, Nixon IR, Yii MY, Zimmet A, Wright GM. VATS left ventricular epicardial lead insertion for cardiac resynchronisation therapy. Australasian Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting, Cairns, Queensland, Australia. 25-28th October 2006. Heart, Lung and Circulation 2007;16:S44.
  • Young R, Yap CH, Miller F, Adair L, Watters DAK. Colonoscopy: A long wait to be seen and a long wait to be scoped – how do we improve? Royal Australasian College of Surgeons Annual Scientific Congress. Sydney, Australia. 15-19th May 2006. ANZ J Surg 2006; 76(Suppl 1) A29.
  • Yap CH, Reid C, Yii M, Shardey GC, Rowland MA, Mohajeri M, Skillington PD, Seevanayagam S, Smith JA. Euroscore overpredicts mortality within the ASCTS database. Australasian Society of Cardiac and Thoracic Surgeons Annual Scientific Meeting, Noosa Heads, Queensland, Australia. 30th October 2005. Heart, Lung and Circulation 2006; 15:98.

More presentations available upon request.

View More